Intracranial Hemorrhage Complicating Anticoagulant Prophylactic Therapy in Three Hospitalized COVID-19 Patients

J Neurovirol. 2020 Jun 22;1-3. doi: 10.1007/s13365-020-00869-6. Online ahead of print.


SARS-CoV2 has led to a global pandemic affecting almost 3 million people in almost over 3 months. Various clinical presentations have been reported so far and no definite therapy is established. Anticoagulation is recommended by several experts to address the potential prothrombotic complications from COVID-19, but its safety and regimen need further clinical trials and safety and efficacy profile. Here, we present three cases of intracranial hemorrhage in three critically ill patients with COVID-19 and discuss their course in relation to various regimens of anticoagulation used.

Keywords: Anticoagulation; COVID-19; Intracranial hemorrhage.